WHO ARE TETRAMED?
TetraMed is seeking to become a vertically integrated medicinal cannabis business, by cultivating and extracting cannabis in Lesotho, then manufacturing and distributing cannabinoid medicines for therapeutic administration.
Initial operations to commence in the Kingdom of Lesotho on a 40 Hectare site.
Targeting first harvest and extraction Q3 2020
LICENCE & LAND
Granted a narcotic operator licenses in Lesotho, the first country in Africa to legalize cannabis production.
Licences allow 60,000m² of cultivation.
The licences allow TetraMed to cultivate, harvest, process, transport, import and export cannabis products within the international regulatory framework required by the INCB.
CULTIVATION & EXTRACTION
TetraMed will cultivate medicinal cannabis within its proposed sophisticated greenhouse facilities in Lesotho.
The harvested cannabis will be processed into oils and concentrated resin material in the proposed on-site extraction facilities.
Developing cannabinoid medicine in a tablet form
The tablet and dissolvable tablet are intended to provided patients with a familiar method to administer their medication.
PROGRESS TO DATE
Secured 400,000m² property through a 20-year lease
$3.1 million raised to date
All initial production has been contracted for sale into Europe
GREENHOUSE & SITE PLANS
Developing a fully-licensed, GMP compliant modular production facility for medicinal where medicinal cannabis will be grown, extracted, processed, and manufactured for global distribution to pharmaceutical companies.
SITE PREPARATION PROGRESS
- Designed modular greenhouse facility
- Water boreholes drilled
- Civil works nearing completion
- Existing offices and storage buildings being fitted out.